Arkolith/Insider Trading/TRML/Form 4

Kulkarni Sandeep Chidambar

CEO, DirectorTourmaline Bio, Inc. (TRML) · full profile →Form 4 · filed Aug 20, 2024
Net Buying
Open-Market Buys
$72K
Open-Market Sells
$0
Net Open-Market Flow
$72K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2024Buy(P)5K$13.79$72K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001827506-24-000074) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML